Yi-Ting Chang - Concepedia

Author

Yi-Ting Chang

Taipei Medical University

Also Known As

Yi-Ting Chang

Publications

383

Citations

H-Index

Concepts

All Affiliations

Taipei Medical University National Health Research Institutes University of California, Davis National Yang Ming Chiao Tung University UC Davis Comprehensive Cancer Center

About

Yi-Ting Chang is an author at Taipei Medical University specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	219
2	Cell Biology	3	3	195
3	Endocrinology	2	2	135
4	Immunology	1	1	70
5	Pathology	1	1	70

Yi-Ting Chang

Publications

372

Citations

H-Index

Page 1

	Year	Citations
Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells Pei‐Ching Chang, Tao-Yeuan Wang, Yi-Ting Chang, PLoS ONE MitophagyImmunologyCell DeathPathologyTumor Biology	2014	70
REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling Tzu‐Ping Lin, Yi-Ting Chang, Sung-Yuan Lee, Oncotarget MitophagyRest ReductionProstate Cancer CellsCell AutophagySignaling Pathway	2016	65
HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer Yi-Ting Chang, Tzu‐Ping Lin, Jui-Ting Tang, Cancer Letters Endocrine-related CancerRest-regulated LncrnaNeuroendocrine DifferentiationLong Non-coding RnaCell Biology	2018	60
MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells Yi-Cheng Lin, Yi-Ting Chang, Mel Campbell, Scientific Reports	2017	56
REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer Yi-Ting Chang, Tzu‐Ping Lin, Mel Campbell, Scientific Reports	2017	55
Furanylazaindoles: Potent Anticancer Agents in Vitro and in Vivo Hsueh‐Yun Lee, Shiow‐Lin Pan, Min-Chieh Su, Journal of Medicinal Chemistry	2013	42
Synthesis and biological evaluation of 7-arylindoline-1-benzenesulfonamides as a novel class of potent anticancer agents Jang‐Yang Chang, Mei-Jung Lai, Yi-Ting Chang, MedChemComm Molecular PharmacologyMedicinal ChemistryMolecular ModelingChemoprevention StrategyPotent Anticancer Agents	2010	24

Page 1